News & ArticlesLatest news and informative articles
S-cubed is pleased to announce the launch of the A3 Community MDR provided free for the benefit of the CDISC user community.
Elizabeth Merrall discusses the case for using real world data (RWD) in clinical research.
We’re at a number of events between now and the end of November, demonstrating our clinical data expertise. Get in touch if you’d like a meeting.
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
This month Darren Jolliffe, explains how S-cubed can assist you in applying the forthcoming regulatory guidance ICH E9(R1)
The CDISC 360 Project is a major change in the way we access and use standards. Our A3 Suite is ready and tuned to the vision.
It’s been a busy few months for S-cubed. Find out where we’ve been and where we’re going to next.
Statistics and the impact of machine learning get Elizabeth Merrall thinking and considering the future.
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
As we head to the CDISC Interchange this week, make sure you see our presentations and meet our team at Stand 11.
S-cubed is pleased to announce that S-cubed and A3 Informatics have merged to bring the A3 Suite of tools inside the S-cubed brand.
Regulatory Affairs and Quality Assurance – S-cubed Ltd are 10 years old. Find out about how our team came together and continue to grow.
The latest papers and presentations from PhUSE US Connect in Baltimore and our future events, including CDISC.
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
A fascinating talk by the Keynote Speaker, Dr Ahadpour from the FDA on the opioid addiction crisis in the USA.
Jakob Sandersen reports on the exciting developments at Pharmaceutical Services ApS over the last 15 months.
Learn all about our presentations at PhUSE US Connect in Baltimore and at the CDISC Interchange in Amsterdam
The final report on the SME Day at EMA focuses on the Committee for Advanced Therapies, new Medical Devices Regulation and a Brexit update.
Our Qlik Team are proud to announce that they have been awarded Pharmaceutical and Biotech Specialization status.
Part Two of the report from the SME Day at the EMA focuses on Marketing Authorisations and more.
Larissa Gould reports from the EMA in Canary Wharf on the latest developments.
Bohua Li introduces an S-cubed extension for adding user comments in a Qlik Sense application, along with a guide for users to implement the extension themselves.
This article provides an overview of PRIME, Breakthrough Therapy and Fast Track regulatory procedures intended to optimise the development of medicines that target an unmet medical need.
Regulatory Affairs Expert Tony Mitchell co-authors a case study for a new IBS Drug This is case study for a joint project S-cubed worked on for a new drug for IBS – PharmaVentures was the lead company and they were providing market valuation expertise, Apex Healthcare...
Sign up to receive our Industry Insights every quarter
Sign up for our newsletter
Download our latest publication
- UK – Fast Track to Ground Breaking Medicines
- US Real Word Data
- Policies Consultations and Guidelines